Purchase of L11 implant exchange and surgical services on non-human primates.
Ended Awarded Last action
- Contract number
- HT942524F0084
- Awardee
-
Harvard Bioscience Inc. UEI MUGFN52A5NJ1 Part of Harvard Bioscience Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $106,607
Award facts
- Contract value 100% obligated
- $106,606.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- ABER PROV GRD, MD 21010, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $3,233 | |
| Supplemental Agreement for work within scope | -$3,233 | |
| Supplemental Agreement for work within scope | $3,233 | |
| Supplemental Agreement for work within scope | -$3,233 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $106,607 |
About this award
The Defense Health Agency awarded a $106,606.88 firm fixed-price call order to Harvard Bioscience Inc. (operating as Data Sciences International) for L11 implant exchange and surgical services on non-human primates. The work will be performed at Aberdeen Proving Ground, Maryland, with an ultimate completion date of January 14, 2025. This contract was issued without a set-aside designation and represents a task order under Harvard Bioscience's existing $4.8 million blanket purchase agreement with the Defense Health Agency, which was awarded in May 2022 and runs through May 3, 2027. The BPA enables streamlined procurement of specialized biomedical research solutions across the military health system.
Harvard Bioscience is a self-certified small disadvantaged business headquartered in New Brighton, Minnesota, and serves as a critical supplier of advanced physiological monitoring technologies and surgical services to federal research programs. The company specializes in wireless implantable telemetry systems, implantable devices including the L11 implants specified in this order, and surgical implantation procedures for preclinical research with various animal models including non-human primates. Since the establishment of the Defense Health Agency BPA, Harvard Bioscience has generated over $1.5 million in cumulative procurement value through task orders, with this call order representing continued support for the Defense Health Agency's and Army Medical Command's biomedical research initiatives.
Quick answers
Who was awarded contract HT942524F0084?
HT942524F0084 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on April 1, 2024.
How much is contract HT942524F0084 worth?
The government has obligated $106,607 on HT942524F0084.
Is contract HT942524F0084 an order under another contract?
Yes. HT942524F0084 is a BPA call under W81XWH22A0001, a blanket purchase agreement.
Was contract HT942524F0084 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award